Tomoki Nakajima

1.7k citations

45 papers · 1.3k indexed · h-index 20

Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 6
Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 6
- Hepatitis B Virus Studies 4
Applied Microbiology and Biotechnology top 10%
Cancer Research top 10%
- Cancer Genomics and Diagnostics 4
Biochemistry top 10%
Oncology
- Cancer-related Molecular Pathways 6
- Pancreatic and Hepatic Oncology Research 3
Physiology
- Telomeres, Telomerase, and Senescence 5
Molecular Biology
- Cell death mechanisms and regulation 3

Co-authors: Takeshi Okanoue Yoshito Itoh Tatsuo Katagishi Keizo Kagawa Hiroyuki Kimura Masahito Minami Hidetaka Takashima Michihisa Moriguchi
Cited by: Hepatology Epidemiology Applied Microbiology and Biotechnology
Partner nations: Japan

In The Last Decade

Tomoki Nakajima

42 papers receiving 1.2k citations

Peers

Countries citing papers authored by Tomoki Nakajima

Since Specialization

Citations

This map shows the geographic impact of Tomoki Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoki Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoki Nakajima more than expected).

Fields of papers citing papers by Tomoki Nakajima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoki Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoki Nakajima. The network helps show where Tomoki Nakajima may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tomoki Nakajima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tomoki Nakajima Line = papers co-authored together Tomoki Nakajima links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Co-Cr-W-Pt alloys with high X-ray visibility for next-generation balloon-expandable stents Tomoki Nakajima,Yushi Ito,Kosuke Ueki,Tomokazu Numano,Kyosuke Ueda,Takayuki Narushima	2025	0
2	Formation of unique heterogeneous microstructure in biomedical Co-Cr-W-Ni-C alloys by mechanical milling and heat treatment processes Kosuke Ueki,Yuta Mizutani,Tomoki Nakajima,Kyosuke Ueda,Takayuki Narushima,Masaaki Nakai	2025	1
3	Age is a Negative, and Visceral Fat Accumulation is a Positive, Contributor to Hepatic Steatosis, Regardless of the Fibrosis Progression in Non-alcoholic Fatty Liver Disease Tomoki Nakajima,Tomoki Nakashima,Junko Yamaoka,Atsushi Shibuya,Y. Itoh,Takafumi Yoshikawa	2012	7
4	Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma Masayasu Jo,Taichiro Nishikawa,Tomoki Nakajima,Yoshihisa Okada,Kanji Yamaguchi,Hironori Mitsuyoshi,Kohichiroh Yasui,Masahito Minami,Masaki Iwai,Keizo Kagawa,Yoshito Itoh,Toshikazu Yoshikawa	2011	40
5	Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation Taichiro Nishikawa,Tomoki Nakajima,Tatsuo Katagishi,Yoshihisa Okada,Masayasu Jo,Keizo Kagawa,Takeshi Okanoue,Yoshito Itoh,Toshikazu Yoshikawa	2009	30
6	Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma Atsushi Umemura,Yoshito Itoh,Katsuhiko Itoh,Kanji Yamaguchi,Tomoki Nakajima,Hiroaki Higashitsuji,Hitoshi Onoue,Manabu Fukumoto,Takeshi Okanoue,Jun Fujita	2007	49
7	Effects of the Cholecystokinin A Receptor Antagonist Loxiglumide on the Proliferation and Cell Cycle Time of Pancreatic Acinar Cells in Rats Daisuke Kanemitsu,Junichi Sakagami,Tomoko Motoyoshi,Tomoki Nakajima,Keisho Kataoka	2006	5
8	Fenofibrate, a peroxisome proliferator‐activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver Yuichi Harano,Kohichiroh Yasui,Tetsuya Toyama,Tomoki Nakajima,Hironori Mitsuyoshi,Masahito Mimani,Tsutomu Hirasawa,Yoshito Itoh,Takeshi Okanoue	2006	131
9	Prediction of Breakthrough Hepatitis due to Lamivudine-Resistant Hepatitis B Virus by a Sensitive Semiquantitative Assay Using Peptide Nucleic Acids Kojiro Mori,Masahito Minami,Toshihiko Kirishima,Koji Kunimoto,Mika Okita,Mika Nakayama,Akiko Makiyama,Junko Yamaoka,Tomoki Nakajima,Kohichiroh Yasui,Yoshito Itoh,Takeshi Okanoue	2006	5
10	A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins Taichiro Nishikawa,Tomoki Nakajima,Michihisa Moriguchi,Masayasu Jo,Satoru Sekoguchi,Michiaki Ishii,Hidetaka Takashima,Tatsuo Katagishi,Hiroyuki Kimura,M Minami,Yoshito Itoh,Kumiko Kagawa,Takeshi Okanoue	2005	146
11	In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma Hidetaka Takashima,Tomoki Nakajima,Michihisa Moriguchi,Satoru Sekoguchi,Taichiro Nishikawa,Tadashi Watanabe,Tatsuo Katagishi,Hiroyuki Kimura,Masahito Minami,Yoshito Itoh,Keizo Kagawa,Takeshi Okanoue	2005	26
12	Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis Masahito Minami,Yukiko Daimon,Kojiro Mori,Hidetaka Takashima,Tomoki Nakajima,Yoshito Itoh,Takeshi Okanoue	2005	66
13	Tumor size-independence of telomere length indicates an aggressive feature of HCC Tomoki Nakajima,Tatsuo Katagishi,Michihisa Moriguchi,Satoru Sekoguchi,Taichirou Nishikawa,Hidetaka Takashima,Tadashi Watanabe,Hiroyuki Kimura,Masahito Minami,Yoshito Itoh,Keizo Kagawa,Takeshi Okanoue	2004	8
14	Recurrence of hepatocellular carcinoma with rapid growth after spontaneous regression Tomoki Nakajima	2004	11
15	The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin‐8 production Michihisa Moriguchi,Tomoki Nakajima,Hiroyuki Kimura,Tadashi Watanabe,Hidetaka Takashima,Yasuhide Mitsumoto,Tatsuo Katagishi,Takeshi Okanoue,Keizo Kagawa	2002	83
16	Novel Formula for Cell Kinetics in Xenograft Model of Hepatocellular Carcinoma Using Histologically Calculable Parameters Tomoki Nakajima,Keizo Kagawa,Takeshi Deguchi,Hiroyuki Kimura,Masamichi Kakusui,Tatsuo Katagishi,Yasuhide Mitsumoto,Takeshi Okanoue,Kei Kashima,Tsukasa Ashihara	1999	6
17	Cytogenetic analyses of hepatocellular carcinoma by in situ hybridization with a chromosome-specific DNA probe Hiroyuki Kimura,Keizo Kagawa,Takeshi Deguchi,Tomoki Nakajima,Masamichi Kakusui,Toru Ohkawara,Tatsuo Katagishi,Takeshi Okanoue,Kei Kashima,Tsukasa Ashihara	1996	18
18	Identification of apoptotic hepatocytes in situ in rat liver after lead nitrate administration Tomoki Nakajima,Takeshi Deguchi,Keizo Kagawa,Hiroshi Hikita,Kazushige Ueda,Tatsuo Katagishi,Tohru Ohkawara,Masamichi Kakusui,Hiroyuki Kimura,Takeshi Okanoue,Kei Kashima,Tsukasa Ashihara	1995	11
19	Immunohistochemical study on p53 expression in hepatocellular carcinomas. Hiroyuki Kimura,Keizo Kagawa,Masamichi Kakusui,Tohru Ohkawara,Tomoki Nakajima,Kazuo Sakabe,Masafumi Matsumoto,Masayuki Mizuno,Kazushige Ueda,Hiroshi Hikita,Takeshi Deguchi,Takeshi Okanoue,Kei Kashima	1993	6
20	Pneumatosis cystoides intestinalis and trichloroethylene exposure. K Yamaguchi,T Shirai,Katsuhide Shimakura,Taiji Akamatsu,Hidenori Nakama,K Kono,Masahiko Sakato,Takashi Shigeno,S Furuta,Tomoki Nakajima	1985	22

About Tomoki Nakajima

Tomoki Nakajima is a scholar working on Hepatology, Cancer Research and Applied Microbiology and Biotechnology, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Telomeres, Telomerase, and Senescence (5 papers), Hepatitis B Virus Studies (4 papers), Cancer Genomics and Diagnostics (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cell death mechanisms and regulation (3 papers). The work is most often cited by research in Hepatology (325 citations), Epidemiology (449 citations) and Applied Microbiology and Biotechnology (26 citations). Tomoki Nakajima has collaborated with scholars based in Japan. Frequent co-authors include Takeshi Okanoue, Yoshito Itoh, Tatsuo Katagishi, Keizo Kagawa, Hiroyuki Kimura, Masahito Minami, Hidetaka Takashima, Michihisa Moriguchi, Taichiro Nishikawa and Kohichiroh Yasui.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact